Healthcare

Healthcare in India

Healthcare sector in India is one of the largest in terms of employment as well as in revenue. Around 80 % of healthcare rests with private sector. The government healthcare is basically covered in rural area with primary healthcare centre, which provides succour to basic ailments. It also has speciality hospitals in major cities and reputed healthcare in metro cities. However, it is the private sector that provides majority of secondary, tertiary and quaternary care institutions with a major concentration in metros, tier I and tier II cities. India also provides contrast in healthcare with high malnutrition, higher infant mortality rate, under vaccinated children and on the other side, India have medical tourism with world class facilities. The Indian healthcare industry is projected t Read More

Kerala government plans to develop anti-rabies vaccine

Kerala Government is planning to produce anti-rabies vaccine in the state. It will produce the vaccine at the Institute of Animal Health and Veterinary Biologicals (IAH&VB) at Palode near Thiruvananthapuram, under the state Animal Husbandry Department. The institute at present produces viral and bacterial vaccines against cattle and poultry diseases. It plans to produce a total of 10 million doses of both human and animal anti-rabies vaccine. Currently, the state procures vaccine from Hyderabad-based Indian Immunologicals Limited (IIL), a subsidiary of National Dairy Development Board. Read More

India launches new drug for TB

Indian government has launched Bedaquiline, a new anti-TB drug for Drug Resistant TB (DR TB) as part of the Revised National Tuberculosis Control Program (RNTCP). The drug is a new anti-TB drug for treatment of MDR-TB. This new class of drug is a diarylquinoline that specifically targets Mycobacterial ATP synthase, an enzyme essential for supply of energy to Mycobacterium tuberculosis and most other mycobacteria. This drug is indicated for use in the treatment of drug-resistant TB. Bedaquiline is being introduced at six identified tertiary care centres across India. These sites have advanced facilities for laboratory testing and intensive care for patients. Bedaquiline will be given to multi-drug resistant TB patients with resistance to either all fluoroquinolone and/or all second line inj Read More